ReviewBiosensors2025
Nanostructured Materials in Glucose Biosensing: From Fundamentals to Smart Healthcare Applications.
Review in Biosensors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Interfacial Engineering of Ni-C/Ni-O-C Bonds in Carbon Nanotube Composites for High-Performance Non-Enzymatic Glucose Detection in Complex Beverage Matrices.Molecules (Basel, Switzerland) · 2026Article
- Pseudo-two-dimensional multiphysics modeling of mass transport and pseudo-enzymatic kinetics in TiRSC advances · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The rapid development of nanotechnology has significantly transformed the design and performance of glucose biosensors, leading to enhanced sensitivity, selectivity, and real-time monitoring capabilities. This review highlights recent advances in glucose-sensing platforms facilitated by nanomaterials, including metal and metal oxide nanoparticles, carbon-based nanostructures, two-dimensional materials, and metal-organic frameworks (MOFs). The integration of these nanoscale materials into electrochemical, optical, and wearable biosensors has addressed longstanding challenges associated with enzyme stability, detection limits, and invasiveness. Special emphasis is placed on non-enzymatic glucose sensors, flexible and wearable devices, and hybrid nanocomposite systems. The multifunctional properties of nanomaterials, such as large surface area, excellent conductivity, and biocompatibility, have enabled the development of next-generation sensors for clinical, point-of-care, and personal healthcare applications. The review also discusses emerging trends such as biodegradable nanosensors, AI-integrated platforms, and smart textiles, which are poised to drive the future of glucose monitoring toward more sustainable and personalized healthcare solutions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.